161 related articles for article (PubMed ID: 37699004)
1. Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer.
Lumish MA; Walch H; Maron SB; Chatila W; Kemel Y; Maio A; Ku GY; Ilson DH; Won E; Li J; Joshi SS; Gu P; Schattner MA; Laszkowska M; Gerdes H; Jones DR; Sihag S; Coit DG; Tang LH; Strong VE; Molena D; Stadler ZK; Schultz N; Janjigian YY; Cercek A
J Natl Cancer Inst; 2024 Feb; 116(2):299-308. PubMed ID: 37699004
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK
Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.
Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.
Heger U; Sisic L; Nienhüser H; Blank S; Hinz U; Haag GM; Ott K; Ulrich A; Büchler MW; Schmidt T
Ann Surg Oncol; 2018 Aug; 25(8):2418-2427. PubMed ID: 29855828
[TBL] [Abstract][Full Text] [Related]
5. Changing pattern of adenocarcinoma of the esophagogastric junction in recent 10 years: experience at a large tertiary medical center in China.
Wang K; Yang CQ; Duan LP; Yang XS; Xia ZW; Cui RL; Jin Z; McNutt M
Tumori; 2012; 98(5):568-74. PubMed ID: 23235750
[TBL] [Abstract][Full Text] [Related]
6. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
7. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.
Wang LD; Zheng S; Zheng ZY; Casson AG
World J Gastroenterol; 2003 Jun; 9(6):1156-64. PubMed ID: 12800215
[TBL] [Abstract][Full Text] [Related]
8. [Detection and significance of epidermal growth factor receptor mutation in esophageal, esophagogastric junction and gastric cancers].
Lyu X; Huang J; Liu J; Wang W; Su Y; Zhang W; Sun Y; Ying J; Wang J; Sun Y
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):346-50. PubMed ID: 25030589
[TBL] [Abstract][Full Text] [Related]
9. Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada -- an epidemiological study from 1964-2002.
Parfitt JR; Miladinovic Z; Driman DK
Can J Gastroenterol; 2006 Apr; 20(4):271-6. PubMed ID: 16609756
[TBL] [Abstract][Full Text] [Related]
10. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and prognostic outcomes for adenocarcinoma of esophagogastric junction in early-onset patients: a population-based appraisal.
Lai H; Zheng J; Zhou G; Li Y
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14941-14952. PubMed ID: 37606763
[TBL] [Abstract][Full Text] [Related]
12. Cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305
[TBL] [Abstract][Full Text] [Related]
13. The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.
Demicco EG; Farris AB; Baba Y; Agbor-Etang B; Bergethon K; Mandal R; Daives D; Fukuoka J; Shimizu M; Dias-Santagata D; Ogino S; Iafrate AJ; Gaissert HA; Mino-Kenudson M
Mod Pathol; 2011 Sep; 24(9):1177-90. PubMed ID: 21572404
[TBL] [Abstract][Full Text] [Related]
14. Signet ring cell carcinoma of the colorectum: correlations between microsatellite instability, clinicopathologic features and survival.
Kakar S; Smyrk TC
Mod Pathol; 2005 Feb; 18(2):244-9. PubMed ID: 15492759
[TBL] [Abstract][Full Text] [Related]
15. Signet ring gastric and esophageal adenocarcinomas: characteristics and prognostic implications.
Khan N; Donohoe CL; Phillips AW; Griffin SM; Reynolds JV
Dis Esophagus; 2020 Nov; 33(11):. PubMed ID: 32378712
[TBL] [Abstract][Full Text] [Related]
16. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract][Full Text] [Related]
18. Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study.
Gertsen EC; van der Veen A; Brenkman HJF; Brosens LAA; van der Post RS; Verhoeven RHA; Luijten JCHBM; Vissers PAJ; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP
Ann Surg Oncol; 2024 Mar; 31(3):1760-1772. PubMed ID: 38127213
[TBL] [Abstract][Full Text] [Related]
19. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of False-Negative Results of Intraoperative Consultation on Surgical Margins During Resection of Gastric and Gastroesophageal Adenocarcinoma.
McAuliffe JC; Tang LH; Kamrani K; Olino K; Klimstra DS; Brennan MF; Coit DG
JAMA Surg; 2019 Feb; 154(2):126-132. PubMed ID: 30422226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
